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Signaling lymphocytic activation molecule (SLAM) family receptors mediate important regulatory
signals in immune cells, as a result of their exquisite ability to associate with members of the
SLAM-associated protein (SAP) family of adaptors. As discussed herein, recent findings show that
the SLAM and SAP families carry out pivotal functions in innate-like and conventional lymphocytes.
They are critically needed for the development of innate-like lymphocytes such as NKT cells. In
addition, they influence several of the functions of conventional lymphocytes, including the ability
of CD4+ T cells to secrete certain cytokines and mediate B cell help; CD8+ T cell proliferation and
cytokine production; NK cell-mediated cytotoxicity; and B cell antibody production. These unique
functional properties appear to be facilitated by the ability of SLAM-related receptors to serve
as self-ligands during homotypic interactions between immune cells. The importance of the
SLAM-SAP pathway in normal immunity is highlighted by the finding that SAP is mutated in humans
suffering from the immunodeficiency X-linked lymphoproliferative disease.Introduction
Cell-cell interactions are critical in the development, differ-
entiation, and activation of immune cells. These interac-
tions are typically heterotypic, involving two cells of different
lineages. Classical examples of heterotypic interactions
are the contacts between immature T cells and thymic ep-
ithelial cells that allow positive selection of conventional
T cells in the thymus or those of mature cytotoxic lym-
phocytes with virus-infected target cells that trigger lym-
phocyte-mediated cytotoxicity. In some cases, however,
cell-cell interactions are homotypic, involving two cells
of the same immune lineage, e.g., the interactions be-
tween immature double-positive (DP) thymocytes that
lead to selection of NKT cells, a T cell subset with in-
nate-like immune cell characteristics.
The receptor-ligand pairs mediating intercellular inter-
actions in the immune system are varied. Most of them
involve receptors that bind a heterologous ligand (hetero-
typic receptor-ligand interactions), including immuno-
receptors such as the T cell receptor (TCR), which rec-
ognizes an antigen bound to a major histocompatibility
complex (MHC) molecule; co-stimulatory molecules and
their ligands such as CD28 and B7, CTLA-4 and B7, and
CD40 and CD40 ligand (CD40L); and adhesion molecules
and their ligands such as LFA-1 and ICAM-1. These
heterotypic receptor-ligand associations usually occur
during heterotypic cell-cell interactions. In certain cases,
the receptors are self-ligands and, thus, are able to
participate in either homotypic or heterotypic cell-cell698 Immunity 27, November 2007 ª2007 Elsevier Inc.interactions. This form of interaction is typical of most
members of the signaling lymphocytic activation molecule
(SLAM) family of receptors, which act in concert with their
intracellular signaling counterparts, the SLAM-associated
protein (SAP)-related adaptors, to regulate immunity.
Here, we review the biochemical and functional character-
istics of SLAM and SAP families as well as highlight
findings reported in this issue of Immunity on the pivotal
roles of the SLAM-SAP pathway in ‘‘innate lymphocyte’’
differentiation (Griewank et al., 2007; Li et al., 2007; Horai
et al., 2007). We also discuss the importance of the SLAM-
SAP pathway in lymphocyte activation and its role in
the immunodeficiency X-linked lymphoproliferative (XLP)
disease.
The SLAM Family of Receptors
The SLAM family of receptors is composed of six mem-
bers named SLAM (CD150); 2B4 (CD244); Ly-9 (CD229);
CD84; natural killer, T and B cell antigen (NTB-A; Ly108
in the mouse); and CD2-like receptor activating cytotoxic
cells (CRACC; also named CD319 or CS1) (Engel et al.,
2003; Veillette, 2006a; Ma et al., 2007). These receptors
possess an extracellular segment with two or, in the
case of Ly-9, four immunoglobulin (Ig)-like domains, a sin-
gle transmembrane region, and a cytoplasmic domain
with several tyrosine-based motifs. These tyrosine-based
motifs undergo phosphorylation and recruit SAP-related
adaptors. The expression of SLAM-related receptors is
restricted to cells of hemopoietic lineages, including
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ReviewTable 1. Distribution of SLAM Family Receptors on Immune Cells
SLAM 2B4 NTB-A (Ly108) Ly-9 CD84 CRACC
DP thymocytes ++ ± +++ ++ ++ 
Mature T cells
Resting ±  + ++ ++ 
Activated +++ ++ (CD8+) +++ +++ ++ ++
Mature NKT cells ± ND ± ND ND ND
B cells ++  +++ +++ ++ ++
NK cells  +++ +++ (h) + + +++
Mature DCs +++ +++   ++ ++
Macrophages ± ±  +++ +++ ++
Relative expression of SLAM receptors in various immune cell types, based on published and unpublished data (Engel et al., 2003;
Veillette, 2006a; Ma et al., 2007; A.V., unpublished data). , no expression; ±, weak expression; ++, moderate expression; +++,
strong expression; ND, not determined. Abbreviations: CRACC, CD2-like receptor activating cytotoxic cells; DC, dendritic cell;
DP, double-positive; h, human; NK, natural killer; NTB-A, natural killer, T and B cell antigen; SLAM, signaling lymphocytic activation
molecule.adaptive and innate immune cells (Table 1). Most, if not all,
immune cell types express more than one SLAM family
receptor. All six SLAM-related genes are located within
a 400–500 kilobase (kb) genomic segment on chromo-
some 1 in humans and mice. This feature implies that
the genes that encode the SLAM family were created by
serial gene duplication.
With the exception of 2B4, all SLAM family receptors are
self-ligands (Mavaddat et al., 2000; Romero et al., 2005;
Kumaresan et al., 2002; Martin et al., 2001; Falco et al.,
2004). Intriguingly, there is a marked variation in the appar-
ent affinity of these self-associations (Kdz 0.5–200 mM),
suggesting that the various members of the SLAM family
may modulate immune cell functions to different extents.
Crystallographic determination of the structure of the
NTB-A-NTB-A and CD84-CD84 homodimers indicated
that self-association is mediated by the amino-terminal
variable (V)-type Ig-like (IgV) domain, which enables
head-to-head contact between two monomers (Cao
et al., 2006; Yan et al., 2007). The end-to-end distance of
the extracellular segments of these dimers is estimated
to be between 100 and 140 A˚, a distance similar to that pro-
posed for TCR-MHC or CTLA-4-B7. Thus, SLAM family
members bearing two Ig-like domains are well fit to coloc-
alize with other receptor-ligand pairs known to have crucial
functions during lymphocyte development and activation.
Although a structure of the four-Ig-like domain-bearing
Ly-9 remains to be determined, mutagenesis studies
suggest that Ly-9 also forms homodimers through its
amino-terminal IgV domain (Romero et al., 2005). This
property implies that the end-to-end distance of Ly-9
dimers may be greater and the topography of Ly-9 distribu-
tion at the cell surface may be different, when compared to
those of the other members of the SLAM family.
Unlike its relatives, 2B4 is not a self-ligand. It is involved
in heterotypic associations with CD48, a glycophosphati-
dylinositol (GPI)-linked member of the CD2 family of
receptors broadly expressed on hemopoietic cells (Latch-man et al., 1998; Brown et al., 1998). Like 2B4, CD48 bears
two Ig-like domains in its extracellular segment. A recent
crystallographic analysis showed that, similar to NTB-A
and CD84 homodimers, 2B4-CD48 heterodimers interact
by way of their IgV-like domains (Velikovsky et al., 2007).
Nonetheless, there are features that make this association
quite distinct from the NTB-A-NTB-A interaction. In partic-
ular, most of the contacts between 2B4 and CD48 involve
residues located in loops of the IgV-like domain. In
contrast, a majority of the interactions in NTB-A dimers
implicate residues in strands of this domain. The esti-
mated size of the extracellular segment of the 2B4-CD48
heterodimer is similar to that of the NTB-A-NTB-A and
CD84-CD84 dimers, suggesting that 2B4-CD48 hetero-
dimers can colocalize with SLAM family receptor homo-
dimers at the interface between immune cells.
Considering that all SLAM family receptors except 2B4
are self-ligands and that CD48, the ligand of 2B4, is found
on all cell types expressing 2B4, SLAM-related receptors
have the potential to regulate immunity in the context of
homotypic or heterotypic cell-cell interactions.
The SAP Family of Adaptors
There are three members of the SAP family of adaptors:
SAP, Ewing’s sarcoma-activated transcript-2 (EAT-2),
and EAT-2-related transducer (ERT; in rodents only)
(Engel et al., 2003; Veillette, 2006a; Ma et al., 2007). These
adaptors are essentially composed of only a Src homol-
ogy 2 (SH2) domain, fused to a short C-terminal tail.
SAP is expressed in T cells, NK cells, NKT cells, and
some B cells, including transformed B cell lines and,
perhaps, normal B cells. In contrast, EAT-2 is found
in NK cells, dendritic cells (DCs), and macrophages,
whereas ERT is present in NK cells. The gene that
encodes SAP (SH2D1A in humans or Sh2d1a in mice) is
located on the X chromosome in humans and mice,
whereas the gene that encodes EAT-2 (SH2D1B in human
or Sh2d1b1 in mice) is positioned on chromosome 1 inImmunity 27, November 2007 ª2007 Elsevier Inc. 699
Immunity
Reviewboth species, near the SLAM locus. Through their SH2 do-
main, SAP-related adaptors associate with high affinity
and high specificity with tyrosine-based motifs in the cyto-
plasmic domain of SLAM-related receptors. So far, there
is no definitive evidence that SAP family adaptors interact
with other classes of molecules by way of their SH2
domains.
SAP family members couple SLAM-related receptors to
active biochemical signals (Engel et al., 2003; Veillette,
2006a; Ma et al., 2007). SAP recruits the Src-related
protein tyrosine kinase (PTK) FynT to the SLAM family
receptors, through a second binding surface centered
on arginine 78 in the SAP SH2 domain (Latour et al.,
2001, 2003; Chan et al., 2003). This arginine 78-based
motif directly interacts with the FynT Src homology 3
(SH3) domain, thereby causing recruitment and enzymatic
activation of FynT. The SAP-FynT interaction is specific,
given that the arginine 78-based motif of SAP does not
seem to bind other members of the Src family. Neverthe-
less, this motif can also associate with another SH3
domain-containing molecule, PAK-interacting exchange
factor (PIX) (Gu et al., 2006). The role of this interaction in
SAP-mediated functions is not known.
The aptitude of SAP to recruit FynT enables SLAM fam-
ily receptors to mediate protein tyrosine phosphorylation
signals (Bloch-Queyrat et al., 2005; Chen et al., 2004;
Latour et al., 2001, 2003; Simarro et al., 2004; Chan
et al., 2003). These signals appear to be pivotal for the
function of SAP in immune cells, given that the immune
defects caused by SAP deficiency in CD4+ T cells, NK
cells, and NKT cells (discussed below) are also encoun-
tered in mice lacking FynT (Davidson et al., 2004; Cannons
et al., 2004; Bloch-Queyrat et al., 2005; Gadue et al., 1999;
Eberl et al., 1999). Moreover, a mouse expressing a SAP
mutant unable to bind FynT (SAPR78A ‘‘knockin’’ mouse)
had the same defect in CD4+ T cell functions as SAP-
deficient mice (Davidson et al., 2004). Intriguingly, recent
data indicated that some of the functions of SAP may
occur through a FynT-independent mechanism. In sup-
port of this, it was found that the severe antibody defect
noted in SAP-deficient mice was not observed in FynT-
deficient mice (Cannons et al., 2006; McCausland et al.,
2007). Furthermore, retrovirus-mediated gene transfer of
SAPR78A, like that of wild-type SAP, was apt at restoring
the compromised antibody production in SAP-deficient
mice (Cannons et al., 2006). It is not known whether these
FynT-independent functions of SAP are mediated by other
Src family kinases interacting with SAP through alternative
mechanisms or whether they involve as yet unknown
effectors of SAP.
Unlike SAP, EAT-2 and ERT do not possess the arginine
78-based motif and, thus, are unable to recruit FynT
through this mechanism (Engel et al., 2003; Veillette,
2006a; Ma et al., 2007). Instead, they bear one or two
tyrosines in their C-terminal tail that can undergo tyrosine
phosphorylation and recruit SH2 domain-containing
molecules. This mechanism appears to be crucial for the
function of EAT-2 and ERT because mutation of the C-
terminal tyrosines abrogated the impact of EAT-2 over-700 Immunity 27, November 2007 ª2007 Elsevier Inc.expresssion in mouse NK cells (Roncagalli et al., 2005).
The identity of the downstream effectors of EAT-2 and
ERT is not known.
X-Linked Lymphoproliferative Disease: Where
SAP Meets XIAP and Innate-like Lymphocytes
XLP disease is a rare inherited human immunodeficiency
primarily characterized by a faulty immune response to
Epstein-Barr virus (EBV) infection (Latour and Veillette,
2003; Ma et al., 2007; Morra et al., 2001). In general,
boys suffering from XLP present with a massive lympho-
proliferative illness and a classical hemophagocytic
syndrome, triggered by EBV infection. If untreated, most
patients succumb to this illness. However, treatment
with immunosuppressive drugs, B cell-depleting CD20
antibodies, and/or bone marrow transplantation can lead
to survival. XLP patients also develop hypogammaglobu-
linemias and malignant lymphomas.
Approximately 50%–70% of cases of XLP are due to
mutations of the SH2D1A gene (Coffey et al., 1998; Sayos
et al., 1998; Nichols et al., 1998) (Table 2). These mutations
range from nonsense and missense point mutations,
leading to unstable or nonfunctional SAP proteins, to large
deletions in the SH2D1A gene. The precise immune de-
fects responsible for the clinical manifestations of SAP-
deficient XLP patients are not elucidated (Latour and Veil-
lette, 2003; Ma et al., 2007; Morra et al., 2001). As will be
detailed below, defects involving multiple cell lineages
have been described, including altered CD4+ T cell func-
tions, diminished CD8+ T cell cytotoxicity, reduced NK
cell cytotoxicity, as well as defective antibody production
and memory B cell generation. There is also a near ab-
sence of NKT cells. Although several of these immune
abnormalities can have grave consequences on health,
the marked accumulation of inflammatory cells seen dur-
ing the EBV-triggered lymphoproliferative illness of XLP
is very similar to that seen in other genetic disorders,
such as Griscelli syndrome and Chediak-Higashi syn-
drome, associated with defective cytotoxic immune cell
functions (Fischer et al., 2007). This notion led to the early
belief that defects in cytotoxic cells, including CD8+ T
cells and NK cells, played a major role in the patho-
physiology of XLP.
More recently, characterization of the genetic and
immunological defects of a subset of XLP patients that
has no SH2D1A mutations provided an alternative, per-
haps complementary, view (Rigaud et al., 2006). These
patients present with clinical syndromes analogous to
those of SAP-deficient patients, although distinctions
include a propensity to exhibit splenomegaly as an early
clinical manifestation and an apparent lack of susceptibil-
ity to malignant lymphomas (Table 2). Genetic analyses
showed that these patients carry point mutations or dele-
tions of the gene coding for X-linked inhibitor-of-apoptosis
(XIAP), a member of the family of inhibitor-of-apoptosis
proteins (IAPs) (Vaux and Silke, 2005). In general, these
mutations result in an absence of XIAP protein expression
(Rigaud et al., 2006). Immunological studies demon-
strated that, unlike SAP-deficient humans, XIAP-deficient
Immunity
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SAP Deficiency XIAP Deficiency
Genetic locus Xq25 Xq25
Protein responsible SAP (SH2 domain-containing adaptor) XIAP (inhibitor-of-apoptosis)
Gene responsible SH2D1A BIRC4
Type(s) of mutation found Null (usually), hypomorphic Null, ? hypomorphic
Signaling pathways affected SLAM family receptors, FynT Caspases, ? others (TGF-b, Notch)
Clinical presentations EBV-triggered HPS,
hypogammaglobulinemia, lymphoma
EBV-triggered HPS,
hypogammaglobulinemia, splenomegaly
Immune defects
CD4+ T cells Y Th2 priming [ AICD (in vitro)
CD8+ T cells Y Cytotoxicity [ AICD (in vitro)
NK cells Y Cytotoxicity ? Normal cytotoxicity
B cells Y Antibody production [ AICD (in vitro)
NKT cells Y Numbers (developmental block) Y Numbers (? peripheral homeostasis defect)
Differences between SAP deficiency and XIAP deficiency in humans. Y, decreased; [, increased. Abbreviations: AICD, activation-
induced cell death; EBV, Epstein-Barr virus; HPS, hemophagocytic syndrome; NK, natural killer; Th2, T helper 2; TGF, transforming
growth factor; SAP, signaling lymphocytic activation molecule (SLAM)-associated protein; XIAP, X-linked inhibitor-of-apoptosis
protein. References: Engel et al., 2003; Veillette, 2006a; Ma et al., 2007; Rigaud et al., 2006; Vaux and Silke, 2005.patients have grossly normal NK cell functions. However,
they have a marked reduction of NKT cell numbers in the
periphery, to almost the same extent as SAP-deficient
patients. In addition, peripheral blood lymphocytes and
EBV-immortalized B cells from these individuals have
greatly enhanced sensitivity to apoptotic stimuli such as
CD3 antibodies or Fas ligation in vitro. Because the com-
mon immunological abnormality seen so far in SAP-defi-
cient and XIAP-deficient patients is a pronounced diminu-
tion in the number of NKT cells, it strongly suggests that
defects in NKT cells, rather than NK cells or CD8+ T cells,
are largely responsible for the EBV-induced lymphoprol-
iferative illnesses and hemophagocytic syndromes
observed in XLP.
The mechanisms by which SAP and XIAP control NKT
cell numbers may be quite divergent (Table 2). In the
case of SAP, studies of SAP-deficient mice showed that
there is an early block in the differentiation of NKT cells
in the thymus (Nichols et al., 2005; Pasquier et al., 2005;
Chung et al., 2005). Similar, albeit slightly less extensive,
defects are seen in mice lacking FynT, implying that SAP
regulates NKT cell differentiation in large part through its
association with FynT (Gadue et al., 1999; Eberl et al.,
1999). The situation appears to be different for XIAP. First,
unlike XIAP-deficient humans, XIAP-deficient mice seem
to have normal NKT cell numbers (Rigaud et al., 2006; Har-
lin et al., 2001). Second, there is currently no evidence that
the biochemical pathways involved in SAP signaling and
XIAP signaling intersect at any level. Although SAP oper-
ates with SLAM family receptors and FynT, XIAP is primar-
ily known to bind and inhibit caspases (Vaux and Silke,
2005). And third, in keeping with the role of XIAP as an
inhibitor of apoptosis, it was observed that mature con-
ventional lymphocytes from XIAP-deficient humans, butnot from SAP-deficient humans, are more sensitive to
activation-induced cell death (Rigaud et al., 2006).
Because mature NKT cells exist in a state of chronic partial
activation (presumably by self-lipids) in vivo (Bendelac
et al., 2007; Brigl and Brenner, 2004; Godfrey and Berzins,
2007), it is plausible that NKT cell numbers are reduced in
XIAP-deficient humans as a consequence of enhanced
peripheral destruction of activated mature cells. This elim-
ination may be further enhanced during the widespread
immune cell activation caused by EBV infection.
The demonstration that a large proportion of XLP
patients carry mutations of the SH2D1A gene provided
the first clear indication that SAP-related adaptors and,
presumably, SLAM family receptors play important roles
in immunity (Coffey et al., 1998; Sayos et al., 1998; Nichols
et al., 1998). This hypothesis was further supported by
subsequent analyses of SAP-deficient mice (Wu et al.,
2001; Czar et al., 2001; Yin et al., 2003; Crotty et al.,
2003; Nichols et al., 2005; Pasquier et al., 2005; Chung
et al., 2005; Bloch-Queyrat et al., 2005; Chen et al.,
2005). More recently, it was cemented by studies of
mice lacking individual members of the SLAM family
(SLAM, 2B4, Ly108, Ly-9) and mice lacking the SAP-
related molecules EAT-2 or ERT (Wang et al., 2004; David-
son et al., 2004; Lee et al., 2004; Howie et al., 2005;
Graham et al., 2006; Roncagalli et al., 2005).
The SLAMand SAP Families: Central Players in the
Differentiation of Innate-like Lymphocytes
Innate-like lymphocytes are subsets of lymphocytes ex-
pressing rearranged antigen receptors, thereby qualifying
as antigen-specific lymphocytes (Godfrey and Berzins,
2007; Bendelac et al., 2007; Rodgers and Cook, 2005;
Kearney, 2005; Treiner and Lantz, 2006; Berg, 2007).Immunity 27, November 2007 ª2007 Elsevier Inc. 701
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NKT Cells gd T Cells MAIT Cells
IEL CD8aa
T Cells T-CD4
CD8ab+
T Cells
(itk/ Mice)
MHC
requirement CD1d ND MR-1 MHC Ia MHC II
MHC Ia and
MHC Ib
TCR repertoire Vb8,7,2/Va14-Ja18 (m);
Vb11/Va24-Ja18 (h)
Vg9/Vd2 (h)
Vg3,4/Vd1 (m)
Vb6,8/Va19-Ja33 (m);
Vb2,13/Va7.2-Ja33 (h)
? Oligoclonal ND ND
Recognized
antigen
Glycosphingolipid Nonpeptidic
phospho-Ags (h)
? Hydrophilic
or/and lipid Ags
ND ND ND
Selecting cells Thymocytes ND B cells or ? DCs ND Thymocytes Thymocytes
IL-15-dependent
development
Yes Yes
(epithelial/skin)
ND ? Yes No Yes
SAP-dependent
development
Yes ND No No Yes Yes
Other signaling
involved
PKCq, FynT, NFkB ? FynT, ? Lck, Syk ND ND PKCq CD28
The developmental characteristics of some of the most studied subsets of innate-like T cells are represented. Abbreviations: Ags,
antigens; DCs, dendritic cells; h, human; IEL, intraepithelial lymphocytes; Itk, interleukin-2-inducible T cell kinase; m, mouse; MAIT,
MHC-related 1 (MR-1)-restricted mucosal associated invariant T cells; MHC, major histocompatibility complex; NKT, natural killer
T; T-CD4, thymocyte-selected CD4+ T cells; SAP, signaling lymphocytic activation molecule (SLAM)-associated protein; TCR, T cell
receptor; ND, not determined. References: Godfrey and Berzins, 2007; Bendelac et al., 2007; Rodgers and Cook, 2005; Kearney,
2005; Horai et al., 2007; Li et al., 2007; E. Martin, S.L., and O. Lantz, unpublished data; B. Pasquier and S.L., unpublished data.However, unlike conventional lymphocytes, they bear
antigen receptors that are usually not polymorphic (some-
times even ‘‘invariant’’) and that recognize either self-anti-
gens or simple molecular structures from pathogens.
Innate-like lymphocytes tend to reside in nonlymphoid
tissues and to have markers of memory cells or chronically
activated cells, including certain NK cell markers. Lastly,
when activated, they exhibit faster and more robust effec-
tor functions such as cytokine release, cytotoxicity, or
antibody production. Because these properties are typical
of innate immune cells, these lymphocytes have been
termed ‘‘innate-like’’ lymphocytes. They are thought to
serve as a bridge between the rapidly occurring innate im-
munity and the more slowly occurring adaptive immunity.
Innate-like B cells include B1 cells and marginal zone
(MZ) B cells (Kearney, 2005), whereas innate-like T cells
include NKT cells, MHC-related 1 (MR-1)-restricted mu-
cosal associated invariant T cells (MAIT cells), H2-M3-
restricted T cells, CD8aa intraepithelial lymphocytes
(IELs), gd T cells, and thymocyte-selected CD4+ T cells
(T-CD4 cells) (Table 3) (Godfrey and Berzins, 2007; Bend-
elac et al., 2007; Rodgers and Cook, 2005; Treiner and
Lantz, 2006; Berg, 2007). They also encompass certain
populations of CD8ab T cells that accumulate in mice
lacking Tec family kinases such as Itk (Dubois et al.,
2006; Broussard et al., 2006; Atherly et al., 2006). Like
conventional T cells, most innate-like T cells arise from
DP thymocyte precursors. However, contrary to conven-
tional T cells, which are selected by nonhemopoietic
thymic epithelial cells, innate-like T cells are selected by
hemopoietically derived thymic cells, most probably other
DP thymocytes. Thus, they seem to develop as a conse-
quence of homotypic cell-cell interactions. Although the702 Immunity 27, November 2007 ª2007 Elsevier Inc.functions of innate-like T cells are not well understood,
there is evidence that they can participate in antimicrobial
and antitumor immunity, as well as in immune tolerance
(Godfrey and Berzins, 2007; Bendelac et al., 2007; Rodg-
ers and Cook, 2005; Treiner and Lantz, 2006; Berg, 2007).
Moreover, they may contribute to the pathophysiology of
some autoimmune diseases.
The prototypical innate-like lymphocytes are the NKT
cells (Bendelac et al., 2007; Godfrey and Berzins, 2007;
Brigl and Brenner, 2004) (Table 3). Most NKT cells express
an invariant Va24-positive TCR in humans or Va14-posi-
tive TCR in the mouse. They arise from DP thymocytes
and are positively selected by self-lipids presented by
the class Ib MHC molecule CD1d expressed on other
DP thymocytes. As discussed above, the development
of NKT cells, but not of conventional T cells, is blocked
in SAP-deficient humans and mice, providing additional
evidence for the unique ontogeny of these cells (Nichols
et al., 2005; Pasquier et al., 2005; Chung et al., 2005). In
this issue of Immunity, Griewank et al. pinpointed the
block of NKT cell differentiation in SAP-deficient mice to
the CD24hiCD1d tetramerhiCD69hi stage, after rearrange-
ment of the canonical Va14-positive TCR (Griewank
et al., 2007). Therefore, it occurs early, at or immediately
after the initiation of TCR signaling and positive selection
in NKT cell precursors. Considering this, it was proposed
that SAP-driven signals may be necessary for the positive
selection, proliferation, and/or prevention of negative
selection of immature NKT cells. One obvious scenario
is that SAP-mediated signals are triggered by homotypic
interactions between SLAM family receptors expressed
on DP thymocytes. Compared to other thymocyte sub-
sets, DP thymocytes express the highest amounts of
Immunity
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observed. Importantly, although mice lacking SLAM
showed no reduction of NKT cell numbers, mice devoid
of Ly108 had a50%–70% decrease in NKT cell numbers
in thymus, spleen, and liver. Furthermore, using a ‘‘pseudo
double knockout’’ of SLAM and Ly108, in which bone mar-
row cells from SLAM-deficient mice and Ly108- and
CD1d-double-deficient mice were coinjected into an irra-
diated host, evidence was provided that combined lack of
SLAM and Ly108 caused an even more severe (90%)
depletion of NKT cells. Hence, SLAM and Ly108 seem to
be the predominant SLAM family receptors triggering
the function of SAP during NKT cell development.
Another indication of the role of SLAM family receptors
in NKT cell differentiation came with the characterization
of the Nkt1 locus on mouse chromosome 1 (Jordan
et al., 2007). This locus is in part responsible for the
reduced NKT cell numbers seen in nonobese diabetic
(NOD) mice. Through analyses of congenic mouse strains
and RNA expression, it was observed that certain poly-
morphisms affecting the genes encoding SLAM and
Ly108 correlate with the diminished NKT cell numbers.
The authors also noted a marked reduction of SLAM
expression on DP thymocytes of NOD mice, suggesting
that, in the NOD background, SLAM may be largely
responsible for the decreased NKT cell numbers.
The involvement of SAP in NKT cell differentiation
prompted two groups to examine, in this issue of Immu-
nity, its role in the development of other innate-like lym-
phocytes. Horai et al. (2007) ascertained the participation
of SAP in the development of a population of CD8ab T
cells prominently found in mice lacking the Tec family
kinase, Itk (Dubois et al., 2006; Broussard et al., 2006;
Atherly et al., 2006) (Table 3). These cells have features
of innate-like lymphocytes, namely constitutive expres-
sion of activation or memory markers and rapidly inducible
effector functions. Moreover, they are selected in part by
class Ib MHC molecules expressed on other hemopoietic
cells, probably DP thymocytes. Interestingly, by crossing
Itk-deficient mice with SAP-deficient mice, Horai et al.
determined that SAP was required for selection of these
innate-like CD8+ T cells. In a similar way, Li et al. (2007)
examined the involvement of SAP in the differentiation of
an unusual subpopulation of CD4+ T cells termed T-CD4
(Choi et al., 2005; Li et al., 2005) (Table 3). Although these
cells do not exhibit all the characteristics of innate-like
lymphocytes, they show the typical fast triggering of effec-
tor functions and are selected by MHC molecules
expressed on DP thymocytes. Once again, it was found
that the development of these cells was critically depen-
dent on SAP. Together, these two provocative reports
provide a compelling indication that additional innate-
like T cell populations require the SLAM-SAP pathway
for their development. One issue with these studies is
that the innate-like T cells analyzed were identified in
genetically manipulated mice. It remains to be determined
whether identical cells exist in normal mice, and
whether SAP plays a critical role under a normal setting
as well.It will be important to test the role of SAP in the develop-
ment of other lymphocyte subpopulations known to have
‘‘innate’’ properties. Nevertheless, in the light of the data
available, it is clear that SLAM-related receptors and
SAP (SLAM-SAP), as well as, presumably, FynT, carry
out a pivotal function in at least some innate-like lympho-
cytes. The reason for this exquisite dependency is not
clearly established. In all likelihood, it relates to the fact
that some innate-like lymphocytes are selected at the
DP thymocyte stage through interactions with hemo-
poietically derived cells, probably other DP thymocytes.
As a result, their selection may have evolved to rely in
a critical manner on homotypic interactions between
SLAM family receptors.
A hypothesis for the dependency on SLAM-SAP-FynT
may be that this pathway provides signals that are critical
for positive selection or survival of these cells. Perhaps,
the affinity or avidity of the interactions between their
TCR as well as its coreceptors (in some cases, CD4
and/or CD8) and antigen-MHC on hemopoietically derived
selecting cells is relatively weak, so that it requires an
additional positive signal provided by SLAM-SAP-FynT
to drive differentiation or sustain survival. In this model,
the SAP-dependent signals would complement quantita-
tively or qualitatively the TCR-coreceptor-driven signals.
An alternative hypothesis is that the SLAM-SAP-FynT
pathway mediates signals that inhibit negative selection
of these cells. It is plausible that the signals generated
by TCR and coreceptor engagement on innate-like T cell
precursors are too strong, thereby necessitating an inhib-
itory signal mediated by SLAM-SAP-FynT to prevent neg-
ative selection. Either of these models is consistent with
earlier data showing that FynT can have either a stimula-
tory or an inhibitory impact on antigen receptor signaling
in mature conventional T cells (Davidson et al., 2004;
Yasuda et al., 2002; Utting et al., 2001; Appleby et al.,
1992; Stein et al., 1992).
Recent data indicated that MAIT cells, a subset of
innate-like T cells presumed to be selected by B cells or,
perhaps, DCs, are not lacking in SAP-deficient humans
(E. Martin, S.L., and O. Lantz, unpublished data) (Treiner
and Lantz, 2006). Also, IELs are not missing in SAP-defi-
cient mice (B. Pasquier and S.L., unpublished data).
Therefore, it seems that SAP is dispensable for the differ-
entiation of some innate-like lymphocytes. In principle,
SAP-independent innate-like lymphocyte development
could occur through at least two mechanisms (Figure 1).
The first possibility is if the TCR coreceptor system of
the innate-like cells allows positive selection or prevents
negative selection in the absence of complementary sig-
nals from SAP. This would be a necessary mechanism
for any innate-like lymphocyte selected by nonhemo-
poietic cells, given that the latter cells lack SLAM family re-
ceptors. This may also be the case for innate-like cells se-
lected in the context of nonhomotypic interactions
between immune cells, such as the interactions between
MAIT cells and their selecting B cells or DCs. The hetero-
typic interactions between T cells and B cells or DCs,
which are probably not perfectly matched for expressionImmunity 27, November 2007 ª2007 Elsevier Inc. 703
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ReviewFigure 1. Differential Involvement of SLAM Family Receptors and SAP in Conventional and Innate-like T Cell Development
A model of the differential involvement of SLAM family receptors and SAP in the maturation of mouse double-positive (DP) thymocytes into conven-
tional T cells (left), NKT cells (middle), or MAIT cells (right) is depicted. The differentiation of DP thymocytes into conventional T cells results from in-
teractions of the TCR (plus its coreceptors CD4 and CD8; not shown) with peptides presented by classical MHC molecules expressed on thymic
epithelial cells (TECs). TECs lack SLAM family receptors and, thus, are unable to utilize the SLAM-SAP pathway to promote conventional T cell dif-
ferentiation. In contrast, the development of DP thymocytes into NKT cells is mediated by interactions between an invariant Va14-positive TCR and
glycolipids presented by the class Ib MHC molecule CD1d expressed on other DP thymocytes. DP thymocytes express high amounts of SLAM and
Ly108, which engage in self-associations between DP thymocytes and mediate SAP-dependent signals that promote NKT cell differentiation. Lastly,
the maturation of DP thymocytes into MAIT cells is due to interactions between a semi-invariant Va19-positive TCR that presumably recognizes hy-
drophilic peptides presented by the class Ib MHC molecule MR1 expressed on B cells or, possibly, DCs. It is possible that the affinity of the MAIT cell
TCR for its ligand is such that it enables differentiation in the absence of any need for the SLAM-SAP pathway. Alternatively, MAIT cells may express
other receptors or adaptors (e.g., EAT-2), which provide alternatives to SLAM-SAP.of SLAM family receptors, may not be conducive to pro-
ductive SLAM family receptor signaling. The second pos-
sibility is if other molecules, either coreceptors, adaptors,
or others, are able to substitute for SLAM-SAP in some in-
nate-like lymphocytes. One example is CD8aa IELs, which
reportedly express high amounts of the SAP-related
adaptor EAT-2 (Denning et al., 2007). This may also be
the case with innate-like B cells such as B1 cells and MZ
B cells, which are not known so far to express SAP. These
cells may possess EAT-2 or, perhaps, SLAM family recep-
tor-independent mechanisms that enable them to acquire
innate properties in the absence of these pathways.
The SLAM and SAP Families: Regulators of Mature
Functions in Conventional Lymphocytes
Unlike innate-like lymphocytes, conventional CD4+ T
cells, CD8+ T cells, NK cells, and B cells do not require
the SLAM and SAP families for their development. How-
ever, some of the mature functions of these cells are reg-
ulated by the SLAM-SAP pathway.
SAP plays a critical role in CD4+ T cells. It was reported
that purified CD4+ T cells from patients with XLP exhibited
reduced interleukin-10 (IL-10) release and expression of
inducible costimulator (ICOS) upon activation (Ma et al.,
2005). They also had an attenuated capacity to provide
B cell help in vitro. Likewise, CD4+ T cells from SAP-defi-704 Immunity 27, November 2007 ª2007 Elsevier Inc.cient mice had decreased secretion of T helper 2 (Th2)
cytokines IL-4 and IL-13, diminished ICOS expression,
and elevated CD40L expression in response to stimulation
with antigen receptor-specific antibodies or antigen-MHC
in vitro (Wu et al., 2001; Czar et al., 2001; Davidson et al.,
2004; Cannons et al., 2004, 2006). These various abnor-
malities were accompanied by compromised antibody
responses to viruses such as lymphocytic choriomeningi-
tis virus (LCMV), g-herpesvirus 68, and influenza and par-
asites like Toxoplasma gondii and Shistosoma mansoni
(Cannons et al., 2006; Crotty et al., 2003; Yin et al.,
2003; Chen et al., 2005; Wu et al., 2001; Czar et al.,
2001; Kamperschroer et al., 2006). Similarly, diminished
antibody production was seen in response to immuniza-
tion with T cell-dependent protein antigens (Hron et al.,
2004; Cannons et al., 2006; Davidson et al., 2004; Morra
et al., 2005). The relevance of the CD4+ T cell dysfunction
to this altered humoral immunity was confirmed by adop-
tive transfer experiments (Cannons et al., 2006; Crotty
et al., 2003; Kamperschroer et al., 2006; Morra et al.,
2005).
It is currently unclear which component(s) of the CD4+ T
cell dysfunction are responsible for the altered B cell re-
sponses in SAP-deficient humans and mice. It does not
appear to be the reduced Th2 cytokine secretion per se
because correction of this defect did not improve the
Immunity
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nons et al., 2006; Crotty et al., 2003). Moreover, whereas
the role of SAP in Th2 cytokine production is FynT depen-
dent, the function of SAP in antibody production seems to
be FynT independent (McCausland et al., 2007; Cannons
et al., 2006). It is plausible that the altered expression by
activated CD4+ T cells of ICOS or CD40L, two molecules
required for productive T cell-B cell interactions, is
involved (Cannons et al., 2006). Alternatively, other as
yet undetermined defects may be implicated, including
compromised secretion of other cytokines important for
B cell maturation, impaired migration of CD4+ T cells to
germinal centers (GCs; a region crucial for T cell-regulated
antibody production), or reduced ability of T cells to form
stable contacts with B cells.
Some clues are available regarding the identity of the
SLAM family members that control SAP-dependent func-
tions in CD4+ T cells. First, activated CD4+ T cells are
known to express SLAM, Ly-9, NTB-A (Ly108), and
CD84, suggesting that one or more of these receptors
are involved (Table 1) (Veillette, 2006a; Ma et al., 2007;
Engel et al., 2003). Second, all these SLAM family recep-
tors bind SAP and can mediate SAP-dependent protein
tyrosine phosphorylation signals (Veillette, 2006a; Ma
et al., 2007; Engel et al., 2003). And third, partial Th2 cyto-
kine production defects were observed in vitro with CD4+
T cells from gene-targeted mice lacking SLAM, Ly108, or
Ly-9 (Wang et al., 2004; Davidson et al., 2004; Howie et al.,
2005; Graham et al., 2006). Thus, several members of the
SLAM family may cooperate to enable SAP to regulate
CD4+ T cell functions.
Nonetheless, the results obtained with SLAM family
receptor-deficient mice should be considered with some
caution, as all these mice were studied in a mixed 129/
Sv-C57BL/6 background. There are marked sequence
and functional variations in the SLAM family gene locus
on chromosome 1 between the two mouse strains, and
it is possible that the variations in Th2 cytokine release
between wild-type and mutant mice were due to
sequence differences between the two strains rather
than the gene-targeting events (Veillette et al., 2006). Anal-
yses of mice generated in a pure genetic background will
be crucial to resolving this issue.
An involvement of SAP in CD8+ T cells is also docu-
mented. In vitro studies revealed that CD8+ T cells from
SAP-deficient mice exhibited enhanced proliferation and
cytokine production in response to stimulation with anti-
gen receptor-specific antibodies (Chen et al., 2005).
Moreover, SAP-deficient mice acutely infected by viruses
such as LCMV or g-herpesvirus 68 showed an increased
number of virus-specific CD8+ T cells and a greater
interferon-g production by these cells (Wu et al., 2001;
Chen et al., 2005). These effects correlated with more
efficient viral clearance. The enhancement of CD8+ T cell
numbers and functions in SAP-deficient mice is appar-
ently due to decreased activation-induced cell death
(Chen et al., 2007). Interestingly, during chronic LCMV
infection, SAP-deficient mice also demonstrated a more
severe immunopathology characterized by weight loss,lymphoid organ hypocellularity, and death when com-
pared to wild-type mice (Crotty et al., 2006). This illness
was reminiscent of the EBV-induced lymphoproliferative
syndrome seen in SAP-deficient humans. Importantly,
depletion of CD8+ T cells improved the immunopathology
of SAP-deficient mice, implying that hyperactive CD8+ T
cells were responsible. Based on these various findings,
it was postulated that SAP is an inhibitor of CD8+ T cell
activation. Such an activity may be crucial to preventing
CD8+ T cell-mediated immunopathologies in response to
subacute or chronic viral infections.
A study of cytotoxic T cells (CTLs) obtained from
SAP-deficient patients suggested an additional role of
SAP in CD8+ T cells (Dupre et al., 2005). It was found
that CTLs from SAP-deficient patients had a decrease in
lytic activity toward EBV-infected B cells. Furthermore,
evidence was obtained that this defect was due to a com-
promised ability of SLAM-related receptor 2B4 to promote
polarization of cytolytic granules when engaged by CD48
on target cells. Thus, when CD48 is expressed on target
cells, SAP may be a positive regulator of CD8+ T cell-
mediated cytotoxicity.
Several studies have reported that NK cells from SAP-
deficient patients have reduced cytotoxicity toward
CD48-positive target cells, implying that SAP deficiency
interferes with the capacity of 2B4 to promote NK cell
activation (Parolini et al., 2000; Nakajima et al., 2000; Tan-
gye et al., 2000; Benoit et al., 2000). Likewise, the ability of
NTB-A antibodies to stimulate NK cell-mediated cytotox-
icity in reverse antibody-dependent cellular cytotoxicity
(rADCC) assays was severely compromised (Bottino
et al., 2001). Intriguingly, in the absence of SAP, 2B4
and NTB-A become inhibitory, rather than activating,
receptors (Parolini et al., 2000; Bottino et al., 2001). This
feature would further compromise NK cell functions in
the absence of SAP. In contrast to 2B4 and NTB-A, the
ability of CRACC to stimulate NK cell-mediated killing in
rADCC assays is not affected by SAP deficiency (Bouchon
et al., 2001). Hence, unlike its two relatives, CRACC may
be promoting NK cell activation through a SAP-indepen-
dent mechanism. Altogether, these data imply that SAP
is a positive regulator of NK cell activation. This is most
likely due to the capacity of SAP to couple 2B4 and, per-
haps, NTB-A to FynT, when these SLAM family receptors
are engaged by their ligands on target cells.
An impairment of the capacity of 2B4 to enhance NK
cell-mediated cytotoxicity has also been shown in NK
cells from SAP-deficient mice or mice lacking FynT
(Bloch-Queyrat et al., 2005). One caveat of this model is
that NK cells from 2B4-deficient mice were found to ex-
hibit increased, instead of diminished, killing toward
CD48-positive target cells (Lee et al., 2004). Therefore,
the dominant effect of engagement of mouse 2B4 by
CD48 on target cells may be NK cell inhibition. Paradoxi-
cally, it was later reported that 2B4-deficient NK cells
had decreased killing toward CD48-negative targets,
implying that 2B4 is mediating an activating signal when
it is engaged by CD48 on other NK cells (Lee et al.,
2006). These complex findings have raised substantialImmunity 27, November 2007 ª2007 Elsevier Inc. 705
Immunity
Reviewquestions regarding the function and mechanism of action
of 2B4, and whether the function of 2B4 may differ be-
tween human and mouse NK cells (Veillette, 2006b; Ma
et al., 2007). Currently, a satisfactory resolution of these
issues has not been achieved.
The involvement of SAP-related adaptors EAT-2 and
ERT in the regulation of NK cell activation has been eval-
uated (Roncagalli et al., 2005). Analyses for purified NK
cells from mice lacking EAT-2 or ERT, or from transgenic
mice overexpressing EAT-2 or ERT in NK cells, indicated
that, contrary to SAP, EAT-2 and ERT are negative regula-
tors of NK cell-mediated cytotoxicity and cytokine pro-
duction. Importantly, this function occurred even in the
absence of coculture of NK cells with target cells, implying
that it is evoked by homotypic NK cell-NK cell interactions.
Surprisingly, the inhibitory effect of EAT-2 and ERT is not
limited to SLAM family receptors, as it also involves other
activating receptors such as NKG2D, CD16, NKRP1c
(NK1.1), and Ly49D. However, all these effects seem to
depend on recruitment of EAT-2 and ERT to 2B4. The pre-
cise effectors mediating the inhibitory impact of EAT-2
and ERT are not known. Notably, inhibition is dependent
on tyrosine phosphorylation in the tail of EAT-2 and,
presumably, ERT. Thus, it is possible that, by way of their
phosphorylated C-terminal tyrosines, EAT-2 and ERT
recruit inhibitory molecules with SH2 domains such as
SH2 domain-containing protein tyrosine phosphatase
(SHP)-1, SHP-2, SH2 domain-containing 50 inositol phos-
phatase (SHIP), or Csk. Alternatively, EAT-2 and ERT may
recruit effectors that mediate activating signals, which
over time downregulate NK cell responsiveness through
a mechanism similar to that described for activating
receptor-induced NK cell ‘‘tolerance’’ (Kim et al., 2005).
The role of EAT-2 in human NK cells was not studied as
exhaustively as that in mouse NK cells. However, overex-
pression of EAT-2 in the human NK cell line YT-S sup-
pressed NK cell-mediated cytotoxicity, suggesting that
EAT-2 is also inhibitory in the human system (Roncagalli
et al., 2005). Nevertheless, another group showed that
the ability of SAP-independent SLAM family receptor
CRACC to promote NK cell cytotoxicity in human NK cells
correlated with binding to EAT-2 (Tassi and Colonna, 2005).
Hence, EAT-2 may have the capacity to transduce activat-
ing signals for some SLAM family receptors in human NK
cells. This hypothesis is also consistent with a recent report
indicating that enforced expression of EAT-2 in a T cell line
caused an increase in activation responses (Clarkson et al.,
2007). Therefore, it is conceivable that human EAT-2 can
have either an inhibitory or an activating function, depend-
ing perhaps on the cellular context.
As mentioned earlier, SAP-deficient humans and mice
exhibit a marked impairment of antibody production.
This is accompanied by severe defects in B cell isotype
switching, affinity maturation, and memory B cell genera-
tion, as well as by a lack of GCs in lymphoid organs (Ma
et al., 2005; Hron et al., 2004; Crotty et al., 2003; Al
Alem et al., 2005; Morra et al., 2005). We already dis-
cussed that at least part of these defects are due to abnor-
mal CD4+ T cell functions. However, an intrinsic B cell dys-706 Immunity 27, November 2007 ª2007 Elsevier Inc.function may also exist. In support of this idea, SAP is
expressed not only in T cells but also in some B cells, in-
cluding perhaps GC B cells (Nichols et al., 1998; Al Alem
et al., 2005; Morra et al., 2005). Furthermore, one study
indicated that naive B cells from SAP-deficient mice dem-
onstrated diminished Ig switch recombination and secre-
tion in vitro (Al Alem et al., 2005). Finally, another group
found that transfer of naive B cells from SAP-deficient an-
imals could recreate the impaired B cell functions seen in
SAP-deficient mice (Morra et al., 2005). However, three
other groups that used an independent SAP-deficient
mouse did not confirm this result (Crotty et al., 2003; Can-
nons et al., 2006; Kamperschroer et al., 2006). Consider-
ing all of these, the role of SAP expression in B cells
remains controversial. The creation of a conditionally tar-
geted SAP-deficient mouse, in which SAP expression
can be selectively ablated in T cells or B cells, will help
resolve this debate.
One striking observation made with genetically engi-
neered SAP-deficient mice is that these mice are fully
resistant to pristane-induced lupus, an autoimmune dis-
ease believed to mimic systemic lupus erythematosus in
humans (Hron et al., 2004). In addition, a spontaneous ‘‘re-
vertant’’ of the autoimmune-prone lpr mouse (named
‘‘rpl’’) was determined to carry a point mutation of SAP
resulting in absent SAP protein expression (Komori
et al., 2006). In both cases, the resistance to autoimmunity
is likely due to reduced T cell-B cell cooperation as result
of SAP deficiency.
SLAM family receptors have also been implicated in the
pathophysiology of autoimmunity. The Sle1b locus, which
confers enhanced susceptibility to lupus in mouse strains
like NZM2410, corresponds to the SLAM family gene
locus on chromosome 1 (Wandstrat et al., 2004). In parti-
cular, a polymorphism in the Ly108 gene that results
in altered expression of two splicing isoforms of Ly108
correlated with greater lupus susceptibility in congenic
mouse strains. Evidence suggested that this polymor-
phism yielded an increase in the responsiveness of mature
T cells and a decrease in the deletion of self-reactive
immature B cells (Wandstrat et al., 2004; Kumar et al.,
2006). A related polymorphism of the SLAM family locus
may be associated with human lupus (Tsao et al., 1997;
Moser et al., 1998; Shai et al., 1999).
The SLAM and SAP Families in Other Immune
Cell Types
Members of the SLAM and SAP families are expressed not
only in lymphocytes but also in other hemopoietic cells in-
cluding DCs, macrophages, granulocytes, platelets, and
hemopoietic stem cells (Table 1) (Engel et al., 2003;
Veillette, 2006a; Ma et al., 2007). Consequently, they
may regulate the functions of these cells as well. In keep-
ing with this, defects in macrophage activation were
reported in mice lacking SLAM (Wang et al., 2004). Like-
wise, compromised neutrophil functions were observed
in mice lacking Ly108 (Howie et al., 2005). Can SLAM fam-
ily receptors on antigen-presenting cells such as DCs and
macrophages provide regulatory cues during antigen
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cells or B cells? While this is an attractive possibility, it
must be pointed out that there is up to now no solid ge-
netic evidence supporting this notion.
Conclusions
Recent studies of SAP-deficient humans and mice, as well
as of mice lacking individual members of the SLAM family
or the SAP-related adaptors EAT-2 and ERT, have
provided undeniable evidence that the SLAM and SAP
families carry out critical functions in immune cells. There
is indication that SAP and certain SLAM family receptors,
in particular SLAM and Ly108, mediate crucial signals dur-
ing the early differentiation of innate-like T cells like NKT
cells and others. Three reports published in this issue of
Immunity, coupled to previous results, provide very com-
pelling evidence in support of this idea. This function most
likely relates to the fact that the differentiation of NKT cells
and other innate-like lymphocytes is triggered by interac-
tions between two identical immune cells that express
matched complements of SLAM family receptors. It prob-
ably relies on the property of SLAM family receptors to
engage in self-associations, a feature that would enable
most efficient signaling in the context of homotypic
cell-cell interactions.
There is also solid evidence that SAP-related adaptors
and SLAM family receptors transduce signals that modu-
late the functions of mature conventional lymphocytes,
including CD4+ T cells, CD8+ T cells, B cells, and NK cells.
Some of these effects, like those on T cell proliferation and
cytokine production, appear to be triggered in the context
of homotypic cell-cell interactions, at least in in vitro
assays. Whether this is also the case in vivo remains to
be established. However, effects on other functions
such as target cell-dependent cytotoxicity are probably
initiated during heterotypic cell-cell interactions, for exam-
ple during the contact of a cytotoxic lymphocyte with a tar-
get cell. Although additional work is needed to elucidate
fully the mechanisms involved in SLAM-SAP-dependent
functions in mature lymphocytes, it is reasonable to
speculate that the SLAM and SAP families mediate these
activities in the context of homotypic or heterotypic
cell-cell interactions, depending on the function involved.
Lastly, the identification of SH2D1A mutations in
humans suffering from XLP, coupled with the recent
description of XIAP mutations in another subset of XLP
patients, has suggested that one of the most critical
activities of SAP in vivo is the regulation of innate-like lym-
phocyte differentiation. Indeed, so far, the only common
immune abnormality seen in SAP-deficient and XIAP-defi-
cient humans is a severe contraction of the NKT cell pool.
Although the basis for the NKT cell defect is likely to be
dissimilar in the two conditions, this observation suggests
that the lack of NKT cells and, perhaps, other innate-like
lymphocytes may be largely responsible for the propensity
of XLP patients to develop EBV-triggered lymphoprolifer-
ative illnesses and hemophagocytic syndromes. It also
suggests that NKT cells play a central role in normal
anti-EBV immunity.ACKNOWLEDGMENTS
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